Department of Experimental Transplantation & Immunology
Medicine Branch, Division of Clinical Sciences National Cancer Institute Bethesda,
Maryland 20892 USA
kwak@mail.ncifcrf.gov
The use of dendritic cells to immunize against tumor antigens is
improving the prospects for cancer vaccines. However, caution must be taken
to avoid activating autoimmunity against normal cells (pages 1011−1017).